In summary, we showed that, in a mouse model of NASH/NAFL, RSV administration can improve inflammation and fibrosis, but not steatosis, via inhibition of LPS reactivity that is due to CD14 expression in Kupffer cells. This evidence concerns the gene CD14 and steatosis.